Related Experiment Videos

[Fibronectin level in coronary sinus blood in myocardial ischemia caused by atrial stimulation]

Kardiologiia
|October 1, 1984
PubMed

Insights

Patients with coronary heart disease experienced reduced fibronectin levels during myocardial ischemia. This suggests fibronectin consumption helps maintain antithrombotic function, with levels normalizing post-ischemia.

Area of Science:

  • Cardiology
  • Biochemistry
  • Hematology

Context:

  • Coronary heart disease (CHD) and angina pectoris are significant cardiovascular conditions.
  • Myocardial ischemia, a state of reduced blood flow to the heart muscle, can be induced experimentally.
  • Fibronectin is a key glycoprotein involved in cell adhesion and wound healing.

Purpose:

  • To investigate the levels of fibronectin in myocardial blood during induced ischemia.
  • To determine the dynamic changes in fibronectin concentration in response to ischemic events.
  • To explore the potential role of fibronectin in the antithrombotic response during myocardial ischemia.

Summary:

  • Patients with coronary heart disease and angina pectoris were subjected to induced myocardial ischemia via atrial stimulation.
  • Blood samples collected during ischemia showed significantly lower fibronectin levels compared to baseline.
  • Fibronectin concentrations returned to normal levels within ten minutes after cessation of atrial stimulation.

Impact:

  • Findings suggest that fibronectin is consumed during myocardial ischemia.
  • This consumption may be linked to the maintenance of antithrombotic functions, preventing clot formation.
  • Understanding fibronectin dynamics in ischemia could inform therapeutic strategies for cardiovascular diseases.

Related Concept Videos